Granby Capital Management LLC Boosts Stock Position in Cibus, Inc. (NASDAQ:CBUS)

Granby Capital Management LLC lifted its stake in shares of Cibus, Inc. (NASDAQ:CBUS - Free Report) by 300.0% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 200,000 shares of the company's stock after purchasing an additional 150,000 shares during the period. Cibus accounts for about 0.3% of Granby Capital Management LLC's portfolio, making the stock its 19th largest holding. Granby Capital Management LLC owned approximately 0.76% of Cibus worth $556,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also made changes to their positions in the stock. IFP Advisors Inc acquired a new position in Cibus in the 4th quarter valued at about $36,000. B. Riley Wealth Advisors Inc. acquired a new position in Cibus in the third quarter valued at approximately $44,000. Virtu Financial LLC purchased a new position in Cibus in the third quarter worth approximately $48,000. Sei Investments Co. acquired a new stake in Cibus during the fourth quarter worth $49,000. Finally, XTX Topco Ltd acquired a new stake in Cibus during the fourth quarter worth $61,000. 33.81% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

CBUS has been the subject of a number of research analyst reports. Canaccord Genuity Group lowered their price target on Cibus from $18.00 to $17.50 and set a "buy" rating for the company in a report on Monday. HC Wainwright reaffirmed a "buy" rating and set a $25.00 target price on shares of Cibus in a research note on Friday, March 21st.

Cibus Price Performance

Shares of CBUS stock traded up $0.26 on Thursday, hitting $2.42. The stock had a trading volume of 40,435 shares, compared to its average volume of 151,569. The company's 50 day moving average price is $1.99 and its 200-day moving average price is $2.80. Cibus, Inc. has a 1 year low of $1.40 and a 1 year high of $18.75. The firm has a market capitalization of $79.50 million, a P/E ratio of -0.11 and a beta of 1.70.

Cibus (NASDAQ:CBUS - Get Free Report) last released its earnings results on Thursday, May 8th. The company reported ($0.74) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.70) by ($0.04). The business had revenue of $1.03 million for the quarter, compared to analyst estimates of $1.15 million. Cibus had a negative return on equity of 28.17% and a negative net margin of 10,724.78%. On average, equities analysts forecast that Cibus, Inc. will post -2.96 EPS for the current year.

Cibus Company Profile

Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.